Wiedemann-Steiner syndrome: genes and variants

Explore variant evidence for Wiedemann-Steiner syndrome across 2 analyzed proteins (KMT2A, CHD7). Linked ClinVar records include 26 pathogenic or likely pathogenic variants, 83 variants of uncertain significance and 22 with conflicting classifications.

Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.

Data updated 2026-11-05. Automated aggregation, not a clinical review date.

Download variant evidence (CSV)

Genes linked to Wiedemann-Steiner syndrome

Weakly linked (only a few uncertain records): SMC1A.

Where Wiedemann-Steiner syndrome variants cluster

ClinVar pathogenic and likely pathogenic variants linked to Wiedemann-Steiner syndrome

VariantPositionProtein partClinical label
KMT2A R1154W1154CXXC-typePathogenic / likely pathogenic (★★)
KMT2A C1155Y1155CXXC-typePathogenic / likely pathogenic (★★)
KMT2A C1158Y1158CXXC-typePathogenic / likely pathogenic (★★)
KMT2A C1189R1189CXXC-typePathogenic / likely pathogenic (★★)
KMT2A C1448Y1448PHD-type 1Pathogenic / likely pathogenic (★★)
KMT2A H1456R1456PHD-type 1Pathogenic / likely pathogenic (★★)
KMT2A G1566R1566PHD-type 3Pathogenic / likely pathogenic (★★)
KMT2A L2845P2845Pathogenic / likely pathogenic (★★)
KMT2A G1181D1181CXXC-typePathogenic / likely pathogenic (★)
KMT2A G1181V1181CXXC-typePathogenic / likely pathogenic (★)
KMT2A N1183D1183CXXC-typePathogenic / likely pathogenic (★)
KMT2A C1448R1448PHD-type 1Pathogenic / likely pathogenic (★)
KMT2A R878W878Pathogenic / likely pathogenic (★)
KMT2A C1434F1434PHD-type 1Pathogenic / likely pathogenic (★)
KMT2A C1936Y1936PHD-type 4Pathogenic / likely pathogenic (★)
KMT2A G1940E1940PHD-type 4Pathogenic / likely pathogenic (★)
KMT2A P2633L2633Pathogenic / likely pathogenic (★)
KMT2A R3705P3705FYR C-terminalPathogenic / likely pathogenic (★)
KMT2A I3926L3926SETPathogenic / likely pathogenic (★)
KMT2A P1829T1829Pathogenic / likely pathogenic (★)
KMT2A R1154Q1154CXXC-typePathogenic / likely pathogenic
KMT2A C1155R1155CXXC-typePathogenic / likely pathogenic
KMT2A C1189Y1189CXXC-typePathogenic / likely pathogenic
CHD7 L1748R1748Pathogenic / likely pathogenic
KMT2A Q1587R1587PHD-type 3Pathogenic / likely pathogenic
KMT2A G2024E2024FYR N-terminalPathogenic / likely pathogenic

Which prediction tools work for Wiedemann-Steiner syndrome

Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.

Same protein, different disease

Diseases related to Wiedemann-Steiner syndrome

Frequently asked questions

Which genes have records linked to Wiedemann-Steiner syndrome?

This view contains 2 analyzed proteins: KMT2A, CHD7. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.

What do the clinical classifications mean?

Linked records include 26 pathogenic or likely pathogenic variants, 83 variants of uncertain significance and 22 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.

Does the evidence score change a VUS classification?

No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.

Can I download the variant evidence?

Download the CSV for all 191 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.

About this data

Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.

Download every variant as CSV · Browse all diseases · Methods · About the Center